Elevated serum KL-6 levels have been correlated with the severity of IPF [10] and ILD associated with connective tissue disease [11–14] and may also be a useful predictor of early progression in patients with systemic sclerosis associated ILD [11–13]. This evidence concerns the gene MUC1 and idiopathic pulmonary fibrosis.